Claims & Evidence
Claims reference
Definitions, direct endpoints, evidence tiers and international control codes. Strategic reference — not a legal approval.
Reference content is provided in English, the language of the source dossier.
Skin & Dermocosmetics — Barrier
Claim boundary · Demonstrate a functional or structural change in the stratum corneum. Hydration, occlusion and biological repair are not interchangeable.
Evidence architecture · Primary: one direct barrier endpoint selected in advance. Secondary: hydration, symptoms or imaging. Exploratory: lipids/proteins or microbiome. Preferred design: randomized within-subject or parallel control, controlled environment, prespecified time course and success rule.
Immediate hydration
Definition · Increases stratum-corneum hydration after one application.
Direct endpoint · Corneometry vs baseline and vehicle/untreated control at the claimed time.
Long-lasting hydration
Definition · Maintains hydration above control through the claimed duration.
Direct endpoint · Corneometry time course and area under the curve through the last claimed time.
Reduces transepidermal water loss
Definition · Decreases passive water loss from the skin under standardized conditions.
Direct endpoint · TEWL change vs control after environmental acclimatization.
Strengthens the skin barrier
Definition · Improves resistance to a standardized barrier challenge.
Direct endpoint · Lower post-challenge TEWL deterioration or better resistance vs control.
Accelerates barrier recovery
Definition · Shortens recovery toward the pre-challenge state after controlled disruption.
Direct endpoint · Longitudinal TEWL recovery slope or time-to-recovery vs control.
Restores barrier lipids
Definition · Increases or normalizes directly measured stratum-corneum lipids.
Direct endpoint · Targeted ceramide/lipid quantification in tape-strip samples.
Supports stratum-corneum integrity
Definition · Improves cohesion, desquamation or structural organization of the outer skin.
Direct endpoint · Corneocyte image analysis, FTIR or other prespecified structural endpoint.
Supports microbiome balance
Definition · Maintains or shifts a prespecified microbial profile without an adverse imbalance.
Direct endpoint · Absolute load plus compositional/diversity endpoints in a controlled longitudinal study.
Skin & Dermocosmetics — Aging
Claim boundary · Anchor claims in visible signs or direct mechanical measures. Dermal biomarkers can strengthen the story but do not replace product-level clinical evidence.
Evidence architecture · Primary: 3D wrinkle, mechanical or ultrasound parameter. Secondary: expert grading and consumer relevance. Exploratory: collagen, elastin, glycation or senescence markers. Preferred design: randomized controlled split-face or parallel study, standardized imaging, blinded analysis and duration matched to the biological ambition.
Reduces fine lines
Definition · Decreases a prespecified depth, length, area or volume metric for fine lines.
Direct endpoint · 3D profilometry or calibrated image endpoint in a defined facial region.
Reduces the appearance of wrinkles
Definition · Improves a validated wrinkle score or image metric in the claimed region.
Direct endpoint · Blinded expert grade or 3D wrinkle metric vs control.
Improves firmness
Definition · Increases resistance to controlled skin deformation.
Direct endpoint · Prespecified cutometry or indentometry parameter.
Improves elasticity
Definition · Improves elastic recovery after controlled deformation.
Direct endpoint · Prespecified cutometry elasticity parameter.
Improves dermal density
Definition · Changes a standardized ultrasound measure of dermal echogenicity/density.
Direct endpoint · Blinded, co-registered ultrasound density measure.
Immediate plumping effect
Definition · Temporarily increases apparent volume or reduces surface depression.
Direct endpoint · 3D volume/relief change at the claimed immediate time.
Supports collagen
Definition · Directly modulates collagen synthesis, deposition or degradation in a relevant model.
Direct endpoint · Procollagen/collagen endpoint with viability and appropriate controls.
Helps protect against stress-induced aging signs
Definition · Reduces a defined damage marker after UV, pollution or oxidative stress.
Direct endpoint · Prespecified damage marker vs stressed control plus a clinical bridge for visible claims.
Skin & Dermocosmetics — Sensitive skin
Claim boundary · Separate tolerability, perceived discomfort, visible redness and neuro-inflammatory mechanism. A questionnaire alone cannot prove a biological anti-inflammatory effect.
Evidence architecture · Primary: adverse-reaction incidence, erythema or symptom score according to wording. Secondary: TEWL, hydration and consumer comfort. Exploratory: neurogenic/inflammatory biomarkers. Preferred design: characterized sensitive-skin population, dermatologist supervision, controlled challenge where justified and blinded assessments.
Suitable for sensitive skin
Definition · Shows acceptable tolerability under normal use in a defined sensitive-skin population.
Direct endpoint · Adverse reaction incidence/severity and dermatologist assessment.
Soothes immediately
Definition · Rapidly reduces warmth, stinging or discomfort after application.
Direct endpoint · Prespecified symptom score vs control after a standardized challenge.
Reduces visible redness
Definition · Decreases instrumental or expert-assessed erythema.
Direct endpoint · Mexametry/colorimetry or blinded erythema grading.
Reduces skin reactivity
Definition · Reduces the magnitude of response to a reproducible challenge.
Direct endpoint · Post-challenge response area under the curve vs control.
Reduces tightness and discomfort
Definition · Reduces consumer-reported sensations without implying biological treatment.
Direct endpoint · Validated patient/consumer score with an unbiased questionnaire.
Helps reduce cosmetic itch discomfort
Definition · Reduces itch sensation in a non-disease cosmetic population.
Direct endpoint · Itch NRS/VAS and episode frequency under controlled use.
Post-procedure tolerance
Definition · Is well tolerated and improves comfort after a defined aesthetic procedure.
Direct endpoint · Adverse events plus comfort/redness endpoint under standardized aftercare.
Skin & Dermocosmetics — Pigmentation
Claim boundary · Define the pigment target, calibrate color and include relevant skin tones. Avoid therapeutic “treats melasma” language and unqualified whitening promises.
Evidence architecture · Primary: lesion contrast, melanin index or colorimetric uniformity. Secondary: expert grading and consumer relevance. Exploratory: melanogenesis markers. Preferred design: 8–16 weeks where appropriate, controlled UV exposure/season, co-registered calibrated imaging and analyses by phototype.
Reduces the appearance of dark spots
Definition · Decreases spot contrast, area or intensity in a defined lesion type.
Direct endpoint · Calibrated spot-to-surrounding-skin contrast or melanin index.
Evens skin tone
Definition · Reduces overall chromatic heterogeneity across predefined facial regions.
Direct endpoint · Locked image-derived uniformity index.
Reduces visible hyperpigmentation
Definition · Decreases measured pigmentation for a clearly defined cosmetic condition.
Direct endpoint · Melanin index, colorimetry or pigmented-area measure vs control.
Improves the appearance of melasma
Definition · Improves visible melasma severity without claiming disease treatment.
Direct endpoint · Dermatologist mMASI/MASI plus standardized photography.
Fades the appearance of post-blemish marks
Definition · Reduces contrast or area of post-inflammatory marks.
Direct endpoint · Lesion-level calibrated image/color analysis with new lesions tracked separately.
Brightens dull-looking skin
Definition · Increases visible radiance/luminance without necessarily reducing melanin.
Direct endpoint · Calibrated luminance/gloss or blinded radiance grade.
Reduces the appearance of pigmented dark circles
Definition · Reduces the chromatic component of under-eye dark circles.
Direct endpoint · Segmented color analysis separating pigment, vascular and shadow components.
Skin & Dermocosmetics — Aesthetics
Claim boundary · Keep cosmetic claims focused on appearance, comfort and measured surface/mechanical effects. Tissue healing and treatment claims trigger heightened or medical-device/drug review.
Evidence architecture · Primary: 3D geometry, color, surface or validated clinical grade. Secondary: comfort and consumer perception. Exploratory: barrier/biomarkers. Preferred design: controlled procedure parameters, standardized pose and imaging, comparator or split-area design, and clinically supervised follow-up.
Immediate tightening effect
Definition · Temporarily improves the appearance or measured mechanics of lax-looking skin.
Direct endpoint · 3D displacement/angle or mechanical parameter at the claimed time.
Redefines facial contours
Definition · Improves a prespecified geometric contour metric.
Direct endpoint · Co-registered 3D volume, angle or distance.
Reduces the appearance of under-eye bags
Definition · Decreases under-eye volume, area or clinical grade.
Direct endpoint · 3D volume or blinded clinical grade at standardized time of day.
Refines pores and skin texture
Definition · Reduces visible pore area or surface irregularity.
Direct endpoint · Locked image-analysis pore metric or 3D roughness.
Supports visible post-procedure recovery
Definition · Accelerates return of redness, dryness or discomfort toward baseline.
Direct endpoint · Time-to-recovery for one prespecified sign.
Improves the appearance of mature scars
Definition · Changes color, relief or pliability of a defined mature scar.
Direct endpoint · Validated scar scale plus color/3D surface measurement.
Hair & Scalp — Fiber performance
Claim boundary · Hair fiber is non-living material. “Repair” must describe measured structural, appearance or performance improvement, not biological regeneration.
Evidence architecture · Primary: mechanical, friction, combing, image or color endpoint matched to wording. Secondary: microscopy and consumer relevance. Preferred design: paired randomized tresses from multiple donors, standardized damage/dose/rinse, controlled humidity and hierarchical analysis.
Reduces hair breakage
Definition · Decreases broken fibers under standardized manipulation.
Direct endpoint · Broken-fiber count or mass after repeated brushing.
Strengthens hair fibers
Definition · Increases force or energy to break, or reduces fragility.
Direct endpoint · Single-fiber force–extension parameter with donor-level analysis.
Repairs damaged hair
Definition · Improves a directly measured property of damaged fibers; regeneration is not implied.
Direct endpoint · Friction, breakage, protein loss or cuticle endpoint with two convergent measures.
Makes detangling easier
Definition · Reduces force, work or time required for wet/dry combing.
Direct endpoint · Combing force/energy under standardized dose and rinse.
Controls frizz
Definition · Reduces halo area or flyaway fibers at defined humidity and time.
Direct endpoint · Calibrated frizz image index in a climate chamber.
Defines and holds curls
Definition · Improves curl geometry, grouping and retention.
Direct endpoint · Curl definition/elongation/retention after humidity or movement.
Increases shine
Definition · Increases specular reflection or blinded shine grade.
Direct endpoint · Instrumental/image shine index under fixed geometry.
Protects from heat styling
Definition · Reduces damage caused by a defined thermal exposure.
Direct endpoint · Retention of strength or reduced damage marker vs heat-only control.
Protects from chemical treatments
Definition · Reduces degradation after a defined color, bleach or relaxer process.
Direct endpoint · Mechanical retention, protein loss or cuticle damage vs stress control.
Extends color vibrancy
Definition · Reduces color drift through claimed wash/exposure cycles.
Direct endpoint · ΔE and L*a*b* components after standardized cycles.
Hair & Scalp — Growth
Claim boundary · Separate shedding, anchorage, growth rate, anagen ratio and new-hair count. Fiber or scalp evidence does not establish follicular growth.
Evidence architecture · Primary: prospectively selected hair-count, phototrichogram or growth-rate endpoint. Secondary: diameter, density and perception. Exploratory: follicle biomarkers/ex vivo growth. Preferred design: randomized placebo-controlled 3–6+ month study, tattooed/co-registered area, blinded reading, seasonal control.
Reduces hair shedding
Definition · Reduces the number of hairs lost over a defined period.
Direct endpoint · Standardized shed count or phototrichogram vs placebo and seasonal baseline.
Improves hair anchorage
Definition · Increases extraction resistance or reduces detachable hairs.
Direct endpoint · Validated extraction/anchorage measure plus shedding confirmation.
Increases hair growth rate
Definition · Increases elongation of existing identified hairs per unit time.
Direct endpoint · Repeated macro-imaging of marked hairs in mm/day.
Promotes new hair growth
Definition · Increases newly visible hairs in a repeatedly imaged scalp area.
Direct endpoint · Longitudinal new terminal-hair count in a tattooed area.
Extends the anagen phase
Definition · Increases the proportion of hairs in active growth.
Direct endpoint · Anagen/telogen ratio by phototrichogram or trichogram.
Promotes ex vivo follicle growth
Definition · Increases isolated follicle elongation in culture; mechanistic only.
Direct endpoint · Follicle elongation and viability across multiple donors.
Hair & Scalp — Density
Claim boundary · Density may arise from hair count, diameter, coverage or styling. Use wording that identifies the demonstrated mechanism.
Evidence architecture · Primary: hairs/cm², diameter, 2D/3D volume or scalp-visibility metric. Secondary: strength and perception. Preferred design: co-registered area, fixed styling/lighting and duration matched to a physical or biological mechanism.
Increases hair density
Definition · Increases the number of hairs per unit scalp area.
Direct endpoint · Terminal and vellus hairs/cm² by phototrichogram.
Makes individual hairs thicker
Definition · Increases measured diameter of existing fibers.
Direct endpoint · Hair diameter distribution by microscopy or calibrated imaging.
Makes hair look denser
Definition · Improves visible coverage regardless of cosmetic mechanism.
Direct endpoint · Blinded coverage/scalp-visibility image score.
Increases hair volume
Definition · Increases the geometric envelope of the styled hair mass.
Direct endpoint · 2D/3D hair volume at defined humidity and time.
Reduces visible scalp show-through
Definition · Decreases the proportion of scalp visible through hair.
Direct endpoint · Locked scalp-pixel/hair-pixel ratio under standardized styling.
Hair & Scalp — Scalp biology
Claim boundary · Prove scalp benefits directly. Hair-fiber and sensory endpoints cannot substitute for scalp biological or follicular evidence.
Evidence architecture · Primary: flakes, sebum, hydration, TEWL, redness, pH or microbiome endpoint. Secondary: symptoms and acceptability. Preferred design: marked scalp area, standardized wash routine, controlled environment and product washout where needed.
Reduces visible flakes
Definition · Decreases visible scalp flake amount, area or severity.
Direct endpoint · Standardized clinical grade or calibrated flake image analysis.
Controls excess scalp oil
Definition · Reduces sebum amount or rate of reappearance after washing.
Direct endpoint · Sebumeter/Sebufix at a fixed post-wash interval.
Hydrates the scalp
Definition · Increases surface hydration without increasing greasy appearance.
Direct endpoint · Site-adapted corneometry in a marked scalp window.
Strengthens the scalp barrier
Definition · Improves directly measured scalp barrier function.
Direct endpoint · TEWL in standardized scalp windows, with hair density controlled.
Soothes a sensitive scalp
Definition · Reduces redness, stinging or discomfort in a defined sensitive population.
Direct endpoint · Hierarchical redness and/or symptom endpoint.
Respects physiological scalp pH
Definition · Maintains or returns surface pH toward a predefined range.
Direct endpoint · Calibrated scalp pH change under standardized washing.
Supports scalp microbiome balance
Definition · Maintains or shifts a prespecified microbial profile with relevant scalp outcomes.
Direct endpoint · Absolute load plus compositional analysis linked to flakes/sebum/symptoms.
Hair & Scalp — Multi-ethnic hair
Claim boundary · Inclusivity is a validation design, not a biological claim about ethnicity. Describe measured curl pattern, diameter, color, practices and needs.
Evidence architecture · Primary: treatment effect within each prespecified texture/skin-tone stratum. Secondary: interaction and acceptability. Preferred design: stratified donors/panels, fit-for-texture handling protocols, adequate N per key stratum and transparent subgroup reporting.
Effective across the studied hair textures
Definition · Demonstrates performance separately across prespecified curl/diameter groups.
Direct endpoint · Success within key strata and treatment-by-texture interaction.
Reduces breakage in tightly curled/coiled hair
Definition · Decreases rupture in high-curvature fibers under relevant handling.
Direct endpoint · Breakage count plus mechanical testing across donors.
Eases detangling of textured hair
Definition · Reduces detangling force and time for defined textures.
Direct endpoint · Combing energy and standardized detangling time.
Maintains curls in high humidity
Definition · Retains curl geometry and controls frizz at high relative humidity.
Direct endpoint · Curl retention and frizz index at 85% RH.
Leaves no visible residue on dark hair/scalp
Definition · Avoids white or ashy residue on the studied colors/skin tones.
Direct endpoint · Calibrated contrast/ΔE plus blinded residue grade.
Sun Care — SPF
Claim boundary · SPF primarily measures protection against UV-induced erythema. It does not mean total protection or unlimited extension of sun exposure.
Evidence architecture · Primary: market-accepted static SPF on the final formulation. Secondary: spectrum and photostability. Preferred design: required application dose, validated method, prespecified statistics and label category/rounding rules for each market.
SPF 30 / 50 / 50+
Definition · States the labeled UVB/erythemal protection category.
Direct endpoint · Market-recognized static SPF method and category thresholds.
UVB protection
Definition · Reduces erythemally weighted UV exposure under standardized conditions.
Direct endpoint · SPF matched to the exact label statement.
Very high protection
Definition · Uses the highest protection category permitted by the target market.
Direct endpoint · Measured SPF plus associated UVA criteria and local rounding rules.
Photostable protection
Definition · Maintains spectral protection after a defined UV dose.
Direct endpoint · Pre/post irradiation retention of UV absorbance or protection factor.
Immediate protection
Definition · Provides the claimed protection without a waiting period.
Direct endpoint · Performance measured at the claimed post-application time.
Sun Care — UVA
Claim boundary · UVA protection must be characterized separately from SPF. Broad-spectrum criteria and symbols differ by jurisdiction.
Evidence architecture · Primary: UVA-PF and/or critical wavelength as required locally. Secondary: long-UVA spectrum and photostability. Preferred design: current ISO or local method applied to final formula; lock substrate, irradiation and scaling rules.
UVA protection
Definition · Reduces exposure to UVA radiation according to a defined protection factor.
Direct endpoint · UVA-PF in vivo/in vitro under the applicable market framework.
Broad-spectrum UVA/UVB protection
Definition · Meets the jurisdiction-specific combination of UVB and UVA criteria.
Direct endpoint · SPF plus UVA-PF/critical-wavelength or local broad-spectrum test.
Long-UVA protection
Definition · Attenuates a predefined long-UVA spectral band.
Direct endpoint · Integrated transmittance/absorbance over the stated band.
Helps prevent signs of photoaging
Definition · Reduces UV exposure and supports a demonstrated damage/visible-sign outcome.
Direct endpoint · Compliant UVA/UVB protection plus a relevant damage or longitudinal clinical endpoint.
Sun Care — Water resistance
Claim boundary · Water resistance is measured after controlled immersion. It never means waterproof.
Evidence architecture · Primary: post-immersion SPF and retention under the local method. Secondary: UVA retention and film imaging. Preferred design: standardized immersion cycles, water conditions and pre/post testing; label the exact duration required locally.
Water resistant
Definition · Retains sufficient protection after a standardized water-immersion procedure.
Direct endpoint · Wet SPF and percentage retention under the target-market rule.
Very water resistant
Definition · Retains performance after the more demanding locally defined immersion duration.
Direct endpoint · Post-immersion SPF and local retention criterion.
Sweat resistant
Definition · Retains film or protection after controlled sweating.
Direct endpoint · Protection-factor retention or validated film coverage after sweat.
Sand and rub resistant
Definition · Limits sand adhesion and/or protection loss under defined friction.
Direct endpoint · Adhered sand mass or protection/film retention after standardized rubbing.
Sun Care — Visible light
Claim boundary · There is no visible-light SPF. Define the wavelength band, optical/biological endpoint and pigmentation-relevant population.
Evidence architecture · Primary: spectral transmittance/reflectance or induced-pigmentation endpoint. Secondary: mechanism and consumer acceptability. Preferred design: realistic film dose, calibrated light source, UVA contamination control, pigmented comparator and relevant skin tones.
Visible-light protection
Definition · Reduces transmission across an explicitly defined visible band.
Direct endpoint · Integrated spectral transmittance/reflectance on a realistic product film.
Helps limit visible-light-induced pigmentation
Definition · Reduces a pigment response after controlled visible-light exposure.
Direct endpoint · Longitudinal color/melanin change vs control in responsive phototypes.
Blue-light protection
Definition · Attenuates a defined blue spectral band; the term alone is ambiguous.
Direct endpoint · Band-specific spectral transmission plus separate proof of any claimed benefit.
Sun Care — Inclusive photoprotection
Claim boundary · Demonstrate both protection and acceptability across diverse skin tones. Do not assume one pigment endpoint performs equally across all phototypes.
Evidence architecture · Primary: efficacy and/or cosmetic-acceptability success within prespecified tone strata. Secondary: reapplication, transfer and perception. Preferred design: objective skin-tone measurement plus stratified recruitment and calibrated imaging.
Tested across the studied phototypes
Definition · Documents efficacy or acceptability separately in every included phototype stratum.
Direct endpoint · Stratum-specific success and treatment-by-phototype interaction.
Invisible on the studied skin tones
Definition · Does not create a perceptible white cast at use dose.
Direct endpoint · ΔE/luminance plus blinded grade across relevant tones.
No ashy finish on deeper skin tones
Definition · Avoids grey/ashy appearance on the studied deeper tones.
Direct endpoint · Calibrated color change plus expert/consumer grade.
Helps protect skin prone to hyperpigmentation
Definition · Combines UV/visible protection with evidence relevant to a pigment-prone population.
Direct endpoint · Compliant sunscreen testing plus pigmentation endpoint where claimed.
Uniform protection after reapplication
Definition · Maintains even film coverage and acceptable appearance over repeated applications.
Direct endpoint · Film-uniformity imaging plus protection or validated proxy after cycles.
Beauty Tech & Innovation — Devices
Claim boundary · Validate metrology, cosmetic benefit and safety separately. Intended purpose and claims may trigger medical-device classification.
Evidence architecture · Primary: accuracy/repeatability or direct clinical benefit, depending on the claim. Secondary: usability/adherence. Preferred design: locked device/software version, reference method or sham control, multi-device/operator testing, worst-case settings and representative users.
Accurate measurement
Definition · Produces results close to a traceable reference value.
Direct endpoint · Bias, absolute error and limits of agreement across the use range.
Repeatable and reproducible measurement
Definition · Produces consistent results within and across devices/operators.
Direct endpoint · CV/ICC and variance components in a Gage R&R design.
Improves a skin or hair benefit
Definition · The device directly improves a defined cosmetic outcome.
Direct endpoint · Matched clinical/instrumental endpoint vs sham or control.
Personalizes the routine
Definition · Uses device output to change selection, dose or routine and improve outcomes.
Direct endpoint · Incremental benefit vs standard recommendation in a strategy trial.
Safe and well tolerated in use
Definition · Shows acceptable adverse-event profile at claimed settings.
Direct endpoint · Adverse-event incidence/severity and objective skin checks.
Beauty Tech & Innovation — Imaging
Claim boundary · An illustrative image is not automatically a measurement. Quantitative claims require calibrated acquisition, locked segmentation and analytical validation.
Evidence architecture · Primary: accuracy and repeatability of the image-derived metric. Secondary: sensitivity to change and expert agreement. Preferred design: independent validation dataset, standardized acquisition, co-registration and robust testing across skin tones/hair types.
Objective image quantification
Definition · Converts images into a valid numerical measure of the target sign.
Direct endpoint · Accuracy vs reference/annotation plus repeatability.
Detects subtle change
Definition · Detects real longitudinal change above measurement noise.
Direct endpoint · Smallest detectable change and signal-to-noise ratio.
3D relief or volume measurement
Definition · Quantifies topography, depth or volume from a 3D reconstruction.
Direct endpoint · Geometric error, repeatability and target clinical metric.
Multi-zone mapping
Definition · Spatially compares an optical biomarker or sign across defined regions.
Direct endpoint · Regional stability, correction and prespecified summary metric.
Representative before/after images
Definition · Provides comparable illustrations without misleading selection or acquisition.
Direct endpoint · Protocol compliance for camera, pose, light, distance and selection.
Beauty Tech & Innovation — AI-enabled assessment
Claim boundary · Validate the complete system: data, model, device, acquisition, output, population and intended use. Average performance can conceal material subgroup bias.
Evidence architecture · Primary: externally validated accuracy/calibration for the intended task. Secondary: repeatability, utility and user comprehension. Preferred design: frozen model, independent dataset, multi-expert truth, subgroup error analysis, failure handling, drift control and version traceability.
Reliable automated assessment
Definition · Produces a score that agrees with an expert or instrumental reference.
Direct endpoint · MAE/AUC/ICC with confidence intervals and prespecified thresholds.
Performance equivalent to an expert
Definition · Meets a justified non-inferiority margin for a narrowly defined task.
Direct endpoint · Difference vs multiple experts under a prespecified non-inferiority design.
Equitable performance across studied skin tones
Definition · Maintains acceptable accuracy and calibration in each tone group.
Direct endpoint · Error, sensitivity and calibration by objectively measured tone stratum.
Sensitive to longitudinal change
Definition · Correctly detects real change over repeated assessments.
Direct endpoint · Responsiveness, SDC and agreement with a longitudinal reference.
Relevant personalized recommendations
Definition · Improves decisions or outcomes beyond a standard routine.
Direct endpoint · Prospective decision-utility or incremental-benefit endpoint.
Instant result
Definition · Returns a valid output within the stated time at an acceptable failure rate.
Direct endpoint · End-to-end latency, valid-output rate and stress testing.
Beauty Tech & Innovation — Translational models
Claim boundary · Mechanistic models explain and prioritize. Consumer claims need a direct bridge to the final product and human outcome.
Evidence architecture · Primary: one causal biomarker or tissue endpoint with viability and appropriate controls. Secondary: orthogonal validation. Exploratory: omics. Preferred design: multiple donors, within-donor randomization, realistic exposure, positive/negative controls, multiplicity control and a prespecified clinical bridge.
Mechanism of action demonstrated
Definition · Shows causal modulation of a relevant pathway in a defined model.
Direct endpoint · Primary biomarker plus viability and pathway controls.
Efficacy in human ex vivo skin
Definition · Produces a directly measured effect in viable human explants.
Direct endpoint · Normalized tissue endpoint localized by histology/imaging.
Predictive of clinical benefit
Definition · The model predicts direction or magnitude of an independent human outcome.
Direct endpoint · Prediction performance on independent product/study data.
Protects against a defined stress
Definition · Reduces damage caused by a specified UV/pollution/oxidative challenge.
Direct endpoint · Specific damage marker vs stressed control, with realistic exposure.
Omics signature associated with benefit
Definition · Identifies a gene/protein signature associated with response.
Direct endpoint · Prespecified or independently validated signature with FDR control.
Regulatory control codes
C1 — Routine cosmetic appearance/performance claim
Usually cosmetic if wording stays on appearance, cleansing, conditioning or comfort and is directly substantiated.
C2 — Enhanced biological/repair claim
Needs a strong product-level bridge; structure/function, inflammation, repair or microbiome wording may cross a regulatory boundary.
F1 — Market-specific functional/special claim
Whitening/brightening, wrinkles, acne, hair-loss relief or similar benefits may require special/functional/quasi-drug pathways in some Asian markets.
SUN — Sunscreen-specific regulated claim
SPF/UVA/water-resistance methods, permitted actives, label statements and product classification are market-specific.
TECH — Device/software performance claim
Validate metrology and intended use; classification changes if the claim becomes diagnostic, therapeutic or affects body structure/function.
MED — High medical/therapeutic boundary risk
Do not launch as a routine cosmetic claim without country-specific legal classification and an appropriate regulated pathway.
High-risk wording
Treats melasma, acne, eczema, psoriasis or dandruff disease
Why it is high risk · Disease treatment/prevention; often drug, therapeutic or functional/special pathway.
Safer wording · Improves the appearance of… / reduces visible flakes, only where locally acceptable.
Evidence / pathway needed · Disease pathway or tightly qualified cosmetic evidence plus local legal review.
Stimulates hair growth / prevents hair loss
Why it is high risk · Direct follicular or body-function claim; special/functional/quasi-drug/drug boundary.
Safer wording · Reduces breakage; makes hair look fuller. Keep true growth claims in regulated pathways.
Evidence / pathway needed · Long controlled follicular study and market-specific registration/approval.
Repairs skin / heals scars / regenerates tissue
Why it is high risk · May imply modification of structure, healing or treatment.
Safer wording · Supports barrier recovery; improves the appearance of mature scars.
Evidence / pathway needed · Direct clinical evidence; procedure/device/drug classification review.
Boosts collagen / reverses aging
Why it is high risk · Mechanistic or structure/function implication often exceeds finished-product evidence.
Safer wording · Improves firmness or wrinkle appearance; supports collagen in a defined model.
Evidence / pathway needed · Direct clinical endpoint plus qualified mechanistic bridge.
Dermatologist-level AI / diagnoses skin conditions
Why it is high risk · Medical diagnostic intended purpose and high-performance representation.
Safer wording · Automated cosmetic appearance assessment for a narrowly defined sign.
Evidence / pathway needed · Medical-device/AI pathway or robust non-medical intended-use validation.
Clinically proven / clinically tested
Why it is high risk · Can imply a strength or quality of evidence not actually delivered.
Safer wording · Clinically tested to [specific result], with transparent footnote.
Evidence / pathway needed · Adequate controlled clinical evidence matching the exact representation.
100% protection / waterproof / sunblock
Why it is high risk · Overstates sunscreen performance and conflicts with major-market rules.
Safer wording · SPF/broad spectrum/water resistant for the locally permitted duration.
Evidence / pathway needed · Market-recognized sunscreen tests and mandatory directions/warnings.
Works for all skin tones / all hair types
Why it is high risk · Universal claim is rarely supported and may mask subgroup failure.
Safer wording · Demonstrated across the studied tones/textures.
Evidence / pathway needed · Adequate stratified samples and success in each stated group.